Bernstein Favors India's Cipla, Dr. Reddy's, Sun Pharma, Lupin

The transcript discusses the status and challenges of various COVID-19 vaccine candidates, including AstraZeneca, Pfizer, and indigenous vaccines in India. It highlights the storage challenges of the Pfizer vaccine, the performance of the NIFTY Pharma index, and the impact of digitalization on pharma sales. The speaker also provides stock recommendations and discusses the accessibility of vaccines in India.

What are the potential impacts on the pharma index if vaccine candidates fail?

How has the COVID-19 pandemic influenced digitalization in the healthcare sector?

Which vaccine candidates are being considered for approval in India, and what are their characteristics?